Small bowel motility affects glucose absorption in a healthy man

Area of Science:

• Gastroenterology
• Human Physiology
• Pharmacology

Background:

• Duodenojejunal motility plays a role in nutrient digestion and absorption.
• Understanding the relationship between intestinal contractions and glucose absorption is crucial for digestive health.
• The prokinetic drug cisapride is known to influence gastrointestinal motility.

Purpose of the Study:

• To investigate the relationship between duodenojejunal motor activity and glucose absorption.
• To evaluate the effect of cisapride on duodenojejunal motility and subsequent glucose absorption.

Main Methods:

• Seven healthy males received cisapride or placebo in a randomized, crossover design.
• Duodenojejunal manometry assessed motor activity after nutrient and 3-O-methylglucose (3-OMG) administration.
• Plasma 3-OMG concentrations were measured to determine glucose absorption kinetics.

Main Results:

• Glucose absorption (area under the 3-OMG curve) correlated with the number of antegrade propagated pressure waves (r = 0.49, P < 0.05).
• Cisapride increased the mean amplitude of pressure waves compared to placebo (P < 0.05).
• No significant differences in motility organization or 3-OMG absorption were observed between cisapride and placebo treatments.

Conclusions:

• Short-traveling propagated intestinal contractile activity is linked to glucose absorption in the human small intestine.
• Cisapride enhances duodenojejunal pressure wave amplitude but does not significantly alter motility organization or glucose absorption.
• Further research may explore targeted modulation of intestinal motility for therapeutic benefits.